Baby Formula Makers Abbott and Reckitt See Stocks Slide

Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.A jury in October found the companies not liable in a case alleging their infant formula products caused necrotizing enterocolitis,
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
That baby formula trial Abbott and Reckitt won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing the “widespread misconduct” of defendants Abbott Laboratories Inc. and Mead Johnson.
Abbott stock falls following retrial order in infant formula case
The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, with the latter’s shares also falling by 4.5%. The legal battle revolves around the Whitfield case, which pertains to the alleged link between infant formula and necrotizing enterocolitis (NEC) in premature infants.
Abbott Laboratories Basking In A Sharp Turn In Sentiment
Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
Why Abbott Laboratories (ABT) Went Down On Friday?
We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Reuters25d
Abbott Laboratories
Abbott and Reckitt unit secure win in infant formula trial Abbott and Reckitt's unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on ...